Chapter/Section Purchase

1 Study Coverage
1.1 Biosimilar Monoclonal Antibodies Product Introduction
1.2 Market by Type
1.2.1 Global Biosimilar Monoclonal Antibodies Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Infliximab
1.2.3 Rituximab
1.2.4 Trastuzumab
1.2.5 Adalimumab
1.2.6 Other
1.3 Market by Application
1.3.1 Global Biosimilar Monoclonal Antibodies Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Oncology
1.3.3 Autoimmune Disease
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Biosimilar Monoclonal Antibodies Sales Estimates and Forecasts 2017-2028
2.2 Global Biosimilar Monoclonal Antibodies Revenue Estimates and Forecasts 2017-2028
2.3 Global Biosimilar Monoclonal Antibodies Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Biosimilar Monoclonal Antibodies Sales by Region
2.4.1 Global Biosimilar Monoclonal Antibodies Sales by Region (2017-2022)
2.4.2 Global Sales Biosimilar Monoclonal Antibodies by Region (2023-2028)
2.5 Global Biosimilar Monoclonal Antibodies Revenue by Region
2.5.1 Global Biosimilar Monoclonal Antibodies Revenue by Region (2017-2022)
2.5.2 Global Biosimilar Monoclonal Antibodies Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Biosimilar Monoclonal Antibodies Sales by Manufacturers
3.1.1 Global Top Biosimilar Monoclonal Antibodies Manufacturers by Sales (2017-2022)
3.1.2 Global Biosimilar Monoclonal Antibodies Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Biosimilar Monoclonal Antibodies in 2021
3.2 Global Biosimilar Monoclonal Antibodies Revenue by Manufacturers
3.2.1 Global Biosimilar Monoclonal Antibodies Revenue by Manufacturers (2017-2022)
3.2.2 Global Biosimilar Monoclonal Antibodies Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Biosimilar Monoclonal Antibodies Revenue in 2021
3.3 Global Biosimilar Monoclonal Antibodies Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Biosimilar Monoclonal Antibodies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Biosimilar Monoclonal Antibodies Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Biosimilar Monoclonal Antibodies Sales by Type
4.1.1 Global Biosimilar Monoclonal Antibodies Historical Sales by Type (2017-2022)
4.1.2 Global Biosimilar Monoclonal Antibodies Forecasted Sales by Type (2023-2028)
4.1.3 Global Biosimilar Monoclonal Antibodies Sales Market Share by Type (2017-2028)
4.2 Global Biosimilar Monoclonal Antibodies Revenue by Type
4.2.1 Global Biosimilar Monoclonal Antibodies Historical Revenue by Type (2017-2022)
4.2.2 Global Biosimilar Monoclonal Antibodies Forecasted Revenue by Type (2023-2028)
4.2.3 Global Biosimilar Monoclonal Antibodies Revenue Market Share by Type (2017-2028)
4.3 Global Biosimilar Monoclonal Antibodies Price by Type
4.3.1 Global Biosimilar Monoclonal Antibodies Price by Type (2017-2022)
4.3.2 Global Biosimilar Monoclonal Antibodies Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Biosimilar Monoclonal Antibodies Sales by Application
5.1.1 Global Biosimilar Monoclonal Antibodies Historical Sales by Application (2017-2022)
5.1.2 Global Biosimilar Monoclonal Antibodies Forecasted Sales by Application (2023-2028)
5.1.3 Global Biosimilar Monoclonal Antibodies Sales Market Share by Application (2017-2028)
5.2 Global Biosimilar Monoclonal Antibodies Revenue by Application
5.2.1 Global Biosimilar Monoclonal Antibodies Historical Revenue by Application (2017-2022)
5.2.2 Global Biosimilar Monoclonal Antibodies Forecasted Revenue by Application (2023-2028)
5.2.3 Global Biosimilar Monoclonal Antibodies Revenue Market Share by Application (2017-2028)
5.3 Global Biosimilar Monoclonal Antibodies Price by Application
5.3.1 Global Biosimilar Monoclonal Antibodies Price by Application (2017-2022)
5.3.2 Global Biosimilar Monoclonal Antibodies Price Forecast by Application (2023-2028)
6 North America
6.1 North America Biosimilar Monoclonal Antibodies Market Size by Type
6.1.1 North America Biosimilar Monoclonal Antibodies Sales by Type (2017-2028)
6.1.2 North America Biosimilar Monoclonal Antibodies Revenue by Type (2017-2028)
6.2 North America Biosimilar Monoclonal Antibodies Market Size by Application
6.2.1 North America Biosimilar Monoclonal Antibodies Sales by Application (2017-2028)
6.2.2 North America Biosimilar Monoclonal Antibodies Revenue by Application (2017-2028)
6.3 North America Biosimilar Monoclonal Antibodies Market Size by Country
6.3.1 North America Biosimilar Monoclonal Antibodies Sales by Country (2017-2028)
6.3.2 North America Biosimilar Monoclonal Antibodies Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Biosimilar Monoclonal Antibodies Market Size by Type
7.1.1 Europe Biosimilar Monoclonal Antibodies Sales by Type (2017-2028)
7.1.2 Europe Biosimilar Monoclonal Antibodies Revenue by Type (2017-2028)
7.2 Europe Biosimilar Monoclonal Antibodies Market Size by Application
7.2.1 Europe Biosimilar Monoclonal Antibodies Sales by Application (2017-2028)
7.2.2 Europe Biosimilar Monoclonal Antibodies Revenue by Application (2017-2028)
7.3 Europe Biosimilar Monoclonal Antibodies Market Size by Country
7.3.1 Europe Biosimilar Monoclonal Antibodies Sales by Country (2017-2028)
7.3.2 Europe Biosimilar Monoclonal Antibodies Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Biosimilar Monoclonal Antibodies Market Size by Type
8.1.1 Asia Pacific Biosimilar Monoclonal Antibodies Sales by Type (2017-2028)
8.1.2 Asia Pacific Biosimilar Monoclonal Antibodies Revenue by Type (2017-2028)
8.2 Asia Pacific Biosimilar Monoclonal Antibodies Market Size by Application
8.2.1 Asia Pacific Biosimilar Monoclonal Antibodies Sales by Application (2017-2028)
8.2.2 Asia Pacific Biosimilar Monoclonal Antibodies Revenue by Application (2017-2028)
8.3 Asia Pacific Biosimilar Monoclonal Antibodies Market Size by Region
8.3.1 Asia Pacific Biosimilar Monoclonal Antibodies Sales by Region (2017-2028)
8.3.2 Asia Pacific Biosimilar Monoclonal Antibodies Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Biosimilar Monoclonal Antibodies Market Size by Type
9.1.1 Latin America Biosimilar Monoclonal Antibodies Sales by Type (2017-2028)
9.1.2 Latin America Biosimilar Monoclonal Antibodies Revenue by Type (2017-2028)
9.2 Latin America Biosimilar Monoclonal Antibodies Market Size by Application
9.2.1 Latin America Biosimilar Monoclonal Antibodies Sales by Application (2017-2028)
9.2.2 Latin America Biosimilar Monoclonal Antibodies Revenue by Application (2017-2028)
9.3 Latin America Biosimilar Monoclonal Antibodies Market Size by Country
9.3.1 Latin America Biosimilar Monoclonal Antibodies Sales by Country (2017-2028)
9.3.2 Latin America Biosimilar Monoclonal Antibodies Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Biosimilar Monoclonal Antibodies Market Size by Type
10.1.1 Middle East and Africa Biosimilar Monoclonal Antibodies Sales by Type (2017-2028)
10.1.2 Middle East and Africa Biosimilar Monoclonal Antibodies Revenue by Type (2017-2028)
10.2 Middle East and Africa Biosimilar Monoclonal Antibodies Market Size by Application
10.2.1 Middle East and Africa Biosimilar Monoclonal Antibodies Sales by Application (2017-2028)
10.2.2 Middle East and Africa Biosimilar Monoclonal Antibodies Revenue by Application (2017-2028)
10.3 Middle East and Africa Biosimilar Monoclonal Antibodies Market Size by Country
10.3.1 Middle East and Africa Biosimilar Monoclonal Antibodies Sales by Country (2017-2028)
10.3.2 Middle East and Africa Biosimilar Monoclonal Antibodies Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Celltrion
11.1.1 Celltrion Corporation Information
11.1.2 Celltrion Overview
11.1.3 Celltrion Biosimilar Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Celltrion Biosimilar Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Celltrion Recent Developments
11.2 Pfizer (Hospira)
11.2.1 Pfizer (Hospira) Corporation Information
11.2.2 Pfizer (Hospira) Overview
11.2.3 Pfizer (Hospira) Biosimilar Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Pfizer (Hospira) Biosimilar Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Pfizer (Hospira) Recent Developments
11.3 3SBIO
11.3.1 3SBIO Corporation Information
11.3.2 3SBIO Overview
11.3.3 3SBIO Biosimilar Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 3SBIO Biosimilar Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 3SBIO Recent Developments
11.4 Novartis (Sandoz)
11.4.1 Novartis (Sandoz) Corporation Information
11.4.2 Novartis (Sandoz) Overview
11.4.3 Novartis (Sandoz) Biosimilar Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Novartis (Sandoz) Biosimilar Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Novartis (Sandoz) Recent Developments
11.5 Dr Reddy?s
11.5.1 Dr Reddy?s Corporation Information
11.5.2 Dr Reddy?s Overview
11.5.3 Dr Reddy?s Biosimilar Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Dr Reddy?s Biosimilar Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Dr Reddy?s Recent Developments
11.6 Celgen Biopharma
11.6.1 Celgen Biopharma Corporation Information
11.6.2 Celgen Biopharma Overview
11.6.3 Celgen Biopharma Biosimilar Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Celgen Biopharma Biosimilar Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Celgen Biopharma Recent Developments
11.7 Cadila Healthcare
11.7.1 Cadila Healthcare Corporation Information
11.7.2 Cadila Healthcare Overview
11.7.3 Cadila Healthcare Biosimilar Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Cadila Healthcare Biosimilar Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Cadila Healthcare Recent Developments
11.8 Hisun Pharma
11.8.1 Hisun Pharma Corporation Information
11.8.2 Hisun Pharma Overview
11.8.3 Hisun Pharma Biosimilar Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Hisun Pharma Biosimilar Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Hisun Pharma Recent Developments
11.9 Torrent Pharmaceuticals
11.9.1 Torrent Pharmaceuticals Corporation Information
11.9.2 Torrent Pharmaceuticals Overview
11.9.3 Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Torrent Pharmaceuticals Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Biosimilar Monoclonal Antibodies Industry Chain Analysis
12.2 Biosimilar Monoclonal Antibodies Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Biosimilar Monoclonal Antibodies Production Mode & Process
12.4 Biosimilar Monoclonal Antibodies Sales and Marketing
12.4.1 Biosimilar Monoclonal Antibodies Sales Channels
12.4.2 Biosimilar Monoclonal Antibodies Distributors
12.5 Biosimilar Monoclonal Antibodies Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Biosimilar Monoclonal Antibodies Industry Trends
13.2 Biosimilar Monoclonal Antibodies Market Drivers
13.3 Biosimilar Monoclonal Antibodies Market Challenges
13.4 Biosimilar Monoclonal Antibodies Market Restraints
14 Key Findings in The Global Biosimilar Monoclonal Antibodies Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer